Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LeMaitre VascularSTU:LHU +1.45%98 FCF Margin % is 19.40% as of Jun. 2026, which is 21% above its 10-year median of 16.04. GuruFocus rates STU:LHU with a GF Score™ of 98/100 and a GF Value™ of €81.33 (Modestly Undervalued). Among 814 Medical Devices & Instruments companies, LeMaitre Vascular ranks better than 96.81% on this metric.
The historical rank and industry rank for LeMaitre Vascular's FCF Margin % or its related term are showing as below:
STU:LHU'
s FCF Margin % Range Over the Past 10 Years
Min: 8.89 Med: 16.04 Max: 29.83
Current: 28.05
During the past 13 years, the highest FCF Margin % of LeMaitre Vascular was 29.83%. The lowest was 8.89%. And the median was 16.04%.
STU:LHU's FCF Margin % is ranked better than 96.81% of 814
companies
in the Medical Devices & Instruments industry
Industry Median: -0.72
vs STU:LHU: 28.05
The historical data trend for LeMaitre Vascular's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:LHU vs PLSE, XRAY, ATRC: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's FCF Margin % distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular (STU:LHU) has a FCF Margin % of 19.40% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on LeMaitre Vascular and its competitors. This is 21% above median its historical median of 16.04. Over the past decade, LeMaitre Vascular's FCF Margin % has ranged from 8.89 to 29.83. According to the industry distribution chart, LeMaitre Vascular ranks #26 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 3.2%.
Is LeMaitre Vascular's FCF Margin % too high?
LeMaitre Vascular's current FCF Margin % of 19.40% is 21% above median its 10-year median of 16.04. Over the past 10 years, this metric has ranged from a low of 8.89 to a high of 29.83. Based on the distribution chart, LeMaitre Vascular ranks #26 out of 814 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LeMaitre Vascular has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's FCF Margin % compare to PLSE and XRAY?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #26 out of 814 companies for FCF Margin %. This places LeMaitre Vascular in the top 3% of its industry — outperforming the majority of peers. Historically, LeMaitre Vascular's own FCF Margin % has ranged from 8.89 to 29.83 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on LeMaitre Vascular and its competitors. LeMaitre Vascular's current FCF Margin % is 19.40%, which is 21% above median its own 10-year median of 16.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (STU:LHU) is currently considered Modestly Undervalued. The stock's GF Value™ is €81.33, compared to a current price of €70.00 — trading 13.9% below its estimated fair value. The current FCF Margin % is 19.40%, which is 21% above median its 10-year median of 16.04. LeMaitre Vascular's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For LeMaitre Vascular (STU:LHU), the current FCF Margin % is 19.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LeMaitre Vascular (STU:LHU) Overvalued in 2026?
Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued.
The current stock price of €70.00 is trading 13.9% below its estimated GF Value™ of €81.33.
GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.
Key valuation signals for STU:LHU:
FCF Margin %: 19.40% (21% above median its 10-year median of 16.04)
GF Value™: €81.33 vs. price of €70.00 (13.9% below fair value)
No single metric tells the full story. See the STU:LHU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
98GF Score
Get the complete analysis for STU:LHU
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:LHU has been successfully added to your 
